Global Dementia Drugs Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Dementia Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Dementia Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 MAO Inhibitors
  • 1.2.3 Cholinesterase Inhibitors
  • 1.2.4 Glutamate Inhibitors
• 1.3 Market by Application
  • 1.3.1 Global Dementia Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Dementia Drugs Sales Estimates and Forecasts 2017-2028
• 2.2 Global Dementia Drugs Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Dementia Drugs Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Dementia Drugs Sales by Region
  • 2.4.1 Global Dementia Drugs Sales by Region (2017-2022)
  • 2.4.2 Global Sales Dementia Drugs by Region (2023-2028)
• 2.5 Global Dementia Drugs Revenue by Region
  • 2.5.1 Global Dementia Drugs Revenue by Region (2017-2022)
  • 2.5.2 Global Dementia Drugs Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Dementia Drugs Sales by Manufacturers
  • 3.1.1 Global Top Dementia Drugs Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Dementia Drugs Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dementia Drugs in 2021
• 3.2 Global Dementia Drugs Revenue by Manufacturers
  • 3.2.1 Global Dementia Drugs Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Dementia Drugs Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Dementia Drugs Revenue in 2021
• 3.3 Global Dementia Drugs Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Dementia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Dementia Drugs Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Dementia Drugs Sales by Type
  • 4.1.1 Global Dementia Drugs Historical Sales by Type (2017-2022)
  • 4.1.2 Global Dementia Drugs Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Dementia Drugs Sales Market Share by Type (2017-2028)
• 4.2 Global Dementia Drugs Revenue by Type
  • 4.2.1 Global Dementia Drugs Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Dementia Drugs Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Dementia Drugs Revenue Market Share by Type (2017-2028)
• 4.3 Global Dementia Drugs Price by Type
  • 4.3.1 Global Dementia Drugs Price by Type (2017-2022)
  • 4.3.2 Global Dementia Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Dementia Drugs Sales by Application
  • 5.1.1 Global Dementia Drugs Historical Sales by Application (2017-2022)
  • 5.1.2 Global Dementia Drugs Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Dementia Drugs Sales Market Share by Application (2017-2028)
• 5.2 Global Dementia Drugs Revenue by Application
  • 5.2.1 Global Dementia Drugs Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Dementia Drugs Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Dementia Drugs Revenue Market Share by Application (2017-2028)
• 5.3 Global Dementia Drugs Price by Application
  • 5.3.1 Global Dementia Drugs Price by Application (2017-2022)
  • 5.3.2 Global Dementia Drugs Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Dementia Drugs Market Size by Type
  • 6.1.1 North America Dementia Drugs Sales by Type (2017-2028)
  • 6.1.2 North America Dementia Drugs Revenue by Type (2017-2028)
• 6.2 North America Dementia Drugs Market Size by Application
  • 6.2.1 North America Dementia Drugs Sales by Application (2017-2028)
  • 6.2.2 North America Dementia Drugs Revenue by Application (2017-2028)
• 6.3 North America Dementia Drugs Market Size by Country
  • 6.3.1 North America Dementia Drugs Sales by Country (2017-2028)
  • 6.3.2 North America Dementia Drugs Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Dementia Drugs Market Size by Type
  • 7.1.1 Europe Dementia Drugs Sales by Type (2017-2028)
  • 7.1.2 Europe Dementia Drugs Revenue by Type (2017-2028)
• 7.2 Europe Dementia Drugs Market Size by Application
  • 7.2.1 Europe Dementia Drugs Sales by Application (2017-2028)
  • 7.2.2 Europe Dementia Drugs Revenue by Application (2017-2028)
• 7.3 Europe Dementia Drugs Market Size by Country
  • 7.3.1 Europe Dementia Drugs Sales by Country (2017-2028)
  • 7.3.2 Europe Dementia Drugs Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Dementia Drugs Market Size by Type
  • 8.1.1 Asia Pacific Dementia Drugs Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Dementia Drugs Revenue by Type (2017-2028)
• 8.2 Asia Pacific Dementia Drugs Market Size by Application
  • 8.2.1 Asia Pacific Dementia Drugs Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Dementia Drugs Revenue by Application (2017-2028)
• 8.3 Asia Pacific Dementia Drugs Market Size by Region
  • 8.3.1 Asia Pacific Dementia Drugs Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Dementia Drugs Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Dementia Drugs Market Size by Type
  • 9.1.1 Latin America Dementia Drugs Sales by Type (2017-2028)
  • 9.1.2 Latin America Dementia Drugs Revenue by Type (2017-2028)
• 9.2 Latin America Dementia Drugs Market Size by Application
  • 9.2.1 Latin America Dementia Drugs Sales by Application (2017-2028)
  • 9.2.2 Latin America Dementia Drugs Revenue by Application (2017-2028)
• 9.3 Latin America Dementia Drugs Market Size by Country
  • 9.3.1 Latin America Dementia Drugs Sales by Country (2017-2028)
  • 9.3.2 Latin America Dementia Drugs Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Dementia Drugs Market Size by Type
  • 10.1.1 Middle East and Africa Dementia Drugs Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Dementia Drugs Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Dementia Drugs Market Size by Application
  • 10.2.1 Middle East and Africa Dementia Drugs Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Dementia Drugs Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Dementia Drugs Market Size by Country
  • 10.3.1 Middle East and Africa Dementia Drugs Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Dementia Drugs Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Eisai, Inc
  • 11.1.1 Eisai, Inc Corporation Information
  • 11.1.2 Eisai, Inc Overview
  • 11.1.3 Eisai, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Eisai, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Eisai, Inc Recent Developments
• 11.2 Janssen Pharmaceuticals, Inc
  • 11.2.1 Janssen Pharmaceuticals, Inc Corporation Information
  • 11.2.2 Janssen Pharmaceuticals, Inc Overview
  • 11.2.3 Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Janssen Pharmaceuticals, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Janssen Pharmaceuticals, Inc Recent Developments
• 11.3 Biogen Pharmaceuticals
  • 11.3.1 Biogen Pharmaceuticals Corporation Information
  • 11.3.2 Biogen Pharmaceuticals Overview
  • 11.3.3 Biogen Pharmaceuticals Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Biogen Pharmaceuticals Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Biogen Pharmaceuticals Recent Developments
• 11.4 Forest Laboratories, Inc
  • 11.4.1 Forest Laboratories, Inc Corporation Information
  • 11.4.2 Forest Laboratories, Inc Overview
  • 11.4.3 Forest Laboratories, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Forest Laboratories, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Forest Laboratories, Inc Recent Developments
• 11.5 Eli Lilly and Company
  • 11.5.1 Eli Lilly and Company Corporation Information
  • 11.5.2 Eli Lilly and Company Overview
  • 11.5.3 Eli Lilly and Company Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Eli Lilly and Company Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Eli Lilly and Company Recent Developments
• 11.6 Novartis AG
  • 11.6.1 Novartis AG Corporation Information
  • 11.6.2 Novartis AG Overview
  • 11.6.3 Novartis AG Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Novartis AG Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Novartis AG Recent Developments
• 11.7 Sanofi S.A
  • 11.7.1 Sanofi S.A Corporation Information
  • 11.7.2 Sanofi S.A Overview
  • 11.7.3 Sanofi S.A Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Sanofi S.A Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Sanofi S.A Recent Developments
• 11.8 AstraZeneca GmbH
  • 11.8.1 AstraZeneca GmbH Corporation Information
  • 11.8.2 AstraZeneca GmbH Overview
  • 11.8.3 AstraZeneca GmbH Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 AstraZeneca GmbH Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 AstraZeneca GmbH Recent Developments
• 11.9 F. Hoffmann-La Roche
  • 11.9.1 F. Hoffmann-La Roche Corporation Information
  • 11.9.2 F. Hoffmann-La Roche Overview
  • 11.9.3 F. Hoffmann-La Roche Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 F. Hoffmann-La Roche Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 F. Hoffmann-La Roche Recent Developments
• 11.10 Merck & Co., Inc
  • 11.10.1 Merck & Co., Inc Corporation Information
  • 11.10.2 Merck & Co., Inc Overview
  • 11.10.3 Merck & Co., Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Merck & Co., Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Merck & Co., Inc Recent Developments
• 11.11 Valeant Pharmaceutical International
  • 11.11.1 Valeant Pharmaceutical International Corporation Information
  • 11.11.2 Valeant Pharmaceutical International Overview
  • 11.11.3 Valeant Pharmaceutical International Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 Valeant Pharmaceutical International Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Valeant Pharmaceutical International Recent Developments
• 11.12 Pfizer Inc
  • 11.12.1 Pfizer Inc Corporation Information
  • 11.12.2 Pfizer Inc Overview
  • 11.12.3 Pfizer Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 Pfizer Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Pfizer Inc Recent Developments
• 11.13 Teva Pharmaceuticals Industries
  • 11.13.1 Teva Pharmaceuticals Industries Corporation Information
  • 11.13.2 Teva Pharmaceuticals Industries Overview
  • 11.13.3 Teva Pharmaceuticals Industries Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.13.4 Teva Pharmaceuticals Industries Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Teva Pharmaceuticals Industries Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Dementia Drugs Industry Chain Analysis
• 12.2 Dementia Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Dementia Drugs Production Mode & Process
• 12.4 Dementia Drugs Sales and Marketing
  • 12.4.1 Dementia Drugs Sales Channels
  • 12.4.2 Dementia Drugs Distributors
• 12.5 Dementia Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Dementia Drugs Industry Trends
• 13.2 Dementia Drugs Market Drivers
• 13.3 Dementia Drugs Market Challenges
• 13.4 Dementia Drugs Market Restraints

14 Key Findings in The Global Dementia Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Dementia Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of MAO Inhibitors
• Table 3. Major Manufacturers of Cholinesterase Inhibitors
• Table 4. Major Manufacturers of Glutamate Inhibitors
• Table 5. Global Dementia Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Dementia Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 7. Global Dementia Drugs Sales by Region (2017-2022) & (K Units)
• Table 8. Global Dementia Drugs Sales Market Share by Region (2017-2022)
• Table 9. Global Dementia Drugs Sales by Region (2023-2028) & (K Units)
• Table 10. Global Dementia Drugs Sales Market Share by Region (2023-2028)
• Table 11. Global Dementia Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 12. Global Dementia Drugs Revenue Market Share by Region (2017-2022)
• Table 13. Global Dementia Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 14. Global Dementia Drugs Revenue Market Share by Region (2023-2028)
• Table 15. Global Dementia Drugs Sales by Manufacturers (2017-2022) & (K Units)
• Table 16. Global Dementia Drugs Sales Share by Manufacturers (2017-2022)
• Table 17. Global Dementia Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 18. Global Dementia Drugs Revenue Share by Manufacturers (2017-2022)
• Table 19. Dementia Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
• Table 20. Global Dementia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 21. Global Dementia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia Drugs as of 2021)
• Table 22. Dementia Drugs Manufacturing Base Distribution and Headquarters
• Table 23. Manufacturers Dementia Drugs Product Offered
• Table 24. Date of Manufacturers Enter into Dementia Drugs Market
• Table 25. Mergers & Acquisitions, Expansion Plans
• Table 26. Global Dementia Drugs Sales by Type (2017-2022) & (K Units)
• Table 27. Global Dementia Drugs Sales by Type (2023-2028) & (K Units)
• Table 28. Global Dementia Drugs Sales Share by Type (2017-2022)
• Table 29. Global Dementia Drugs Sales Share by Type (2023-2028)
• Table 30. Global Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 31. Global Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 32. Global Dementia Drugs Revenue Share by Type (2017-2022)
• Table 33. Global Dementia Drugs Revenue Share by Type (2023-2028)
• Table 34. Dementia Drugs Price by Type (2017-2022) & (USD/Unit)
• Table 35. Global Dementia Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
• Table 36. Global Dementia Drugs Sales by Application (2017-2022) & (K Units)
• Table 37. Global Dementia Drugs Sales by Application (2023-2028) & (K Units)
• Table 38. Global Dementia Drugs Sales Share by Application (2017-2022)
• Table 39. Global Dementia Drugs Sales Share by Application (2023-2028)
• Table 40. Global Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 41. Global Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 42. Global Dementia Drugs Revenue Share by Application (2017-2022)
• Table 43. Global Dementia Drugs Revenue Share by Application (2023-2028)
• Table 44. Dementia Drugs Price by Application (2017-2022) & (USD/Unit)
• Table 45. Global Dementia Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
• Table 46. North America Dementia Drugs Sales by Type (2017-2022) & (K Units)
• Table 47. North America Dementia Drugs Sales by Type (2023-2028) & (K Units)
• Table 48. North America Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 49. North America Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 50. North America Dementia Drugs Sales by Application (2017-2022) & (K Units)
• Table 51. North America Dementia Drugs Sales by Application (2023-2028) & (K Units)
• Table 52. North America Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 53. North America Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 54. North America Dementia Drugs Sales by Country (2017-2022) & (K Units)
• Table 55. North America Dementia Drugs Sales by Country (2023-2028) & (K Units)
• Table 56. North America Dementia Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 57. North America Dementia Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 58. Europe Dementia Drugs Sales by Type (2017-2022) & (K Units)
• Table 59. Europe Dementia Drugs Sales by Type (2023-2028) & (K Units)
• Table 60. Europe Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 61. Europe Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 62. Europe Dementia Drugs Sales by Application (2017-2022) & (K Units)
• Table 63. Europe Dementia Drugs Sales by Application (2023-2028) & (K Units)
• Table 64. Europe Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 65. Europe Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 66. Europe Dementia Drugs Sales by Country (2017-2022) & (K Units)
• Table 67. Europe Dementia Drugs Sales by Country (2023-2028) & (K Units)
• Table 68. Europe Dementia Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 69. Europe Dementia Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 70. Asia Pacific Dementia Drugs Sales by Type (2017-2022) & (K Units)
• Table 71. Asia Pacific Dementia Drugs Sales by Type (2023-2028) & (K Units)
• Table 72. Asia Pacific Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 73. Asia Pacific Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 74. Asia Pacific Dementia Drugs Sales by Application (2017-2022) & (K Units)
• Table 75. Asia Pacific Dementia Drugs Sales by Application (2023-2028) & (K Units)
• Table 76. Asia Pacific Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 77. Asia Pacific Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 78. Asia Pacific Dementia Drugs Sales by Region (2017-2022) & (K Units)
• Table 79. Asia Pacific Dementia Drugs Sales by Region (2023-2028) & (K Units)
• Table 80. Asia Pacific Dementia Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 81. Asia Pacific Dementia Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 82. Latin America Dementia Drugs Sales by Type (2017-2022) & (K Units)
• Table 83. Latin America Dementia Drugs Sales by Type (2023-2028) & (K Units)
• Table 84. Latin America Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 85. Latin America Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 86. Latin America Dementia Drugs Sales by Application (2017-2022) & (K Units)
• Table 87. Latin America Dementia Drugs Sales by Application (2023-2028) & (K Units)
• Table 88. Latin America Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 89. Latin America Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 90. Latin America Dementia Drugs Sales by Country (2017-2022) & (K Units)
• Table 91. Latin America Dementia Drugs Sales by Country (2023-2028) & (K Units)
• Table 92. Latin America Dementia Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 93. Latin America Dementia Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 94. Middle East and Africa Dementia Drugs Sales by Type (2017-2022) & (K Units)
• Table 95. Middle East and Africa Dementia Drugs Sales by Type (2023-2028) & (K Units)
• Table 96. Middle East and Africa Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 97. Middle East and Africa Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 98. Middle East and Africa Dementia Drugs Sales by Application (2017-2022) & (K Units)
• Table 99. Middle East and Africa Dementia Drugs Sales by Application (2023-2028) & (K Units)
• Table 100. Middle East and Africa Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 101. Middle East and Africa Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 102. Middle East and Africa Dementia Drugs Sales by Country (2017-2022) & (K Units)
• Table 103. Middle East and Africa Dementia Drugs Sales by Country (2023-2028) & (K Units)
• Table 104. Middle East and Africa Dementia Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 105. Middle East and Africa Dementia Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 106. Eisai, Inc Corporation Information
• Table 107. Eisai, Inc Description and Major Businesses
• Table 108. Eisai, Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 109. Eisai, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 110. Eisai, Inc Recent Developments
• Table 111. Janssen Pharmaceuticals, Inc Corporation Information
• Table 112. Janssen Pharmaceuticals, Inc Description and Major Businesses
• Table 113. Janssen Pharmaceuticals, Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 114. Janssen Pharmaceuticals, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 115. Janssen Pharmaceuticals, Inc Recent Developments
• Table 116. Biogen Pharmaceuticals Corporation Information
• Table 117. Biogen Pharmaceuticals Description and Major Businesses
• Table 118. Biogen Pharmaceuticals Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 119. Biogen Pharmaceuticals Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 120. Biogen Pharmaceuticals Recent Developments
• Table 121. Forest Laboratories, Inc Corporation Information
• Table 122. Forest Laboratories, Inc Description and Major Businesses
• Table 123. Forest Laboratories, Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 124. Forest Laboratories, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 125. Forest Laboratories, Inc Recent Developments
• Table 126. Eli Lilly and Company Corporation Information
• Table 127. Eli Lilly and Company Description and Major Businesses
• Table 128. Eli Lilly and Company Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 129. Eli Lilly and Company Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 130. Eli Lilly and Company Recent Developments
• Table 131. Novartis AG Corporation Information
• Table 132. Novartis AG Description and Major Businesses
• Table 133. Novartis AG Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 134. Novartis AG Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 135. Novartis AG Recent Developments
• Table 136. Sanofi S.A Corporation Information
• Table 137. Sanofi S.A Description and Major Businesses
• Table 138. Sanofi S.A Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 139. Sanofi S.A Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 140. Sanofi S.A Recent Developments
• Table 141. AstraZeneca GmbH Corporation Information
• Table 142. AstraZeneca GmbH Description and Major Businesses
• Table 143. AstraZeneca GmbH Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 144. AstraZeneca GmbH Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 145. AstraZeneca GmbH Recent Developments
• Table 146. F. Hoffmann-La Roche Corporation Information
• Table 147. F. Hoffmann-La Roche Description and Major Businesses
• Table 148. F. Hoffmann-La Roche Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 149. F. Hoffmann-La Roche Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 150. F. Hoffmann-La Roche Recent Developments
• Table 151. Merck & Co., Inc Corporation Information
• Table 152. Merck & Co., Inc Description and Major Businesses
• Table 153. Merck & Co., Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 154. Merck & Co., Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 155. Merck & Co., Inc Recent Developments
• Table 156. Valeant Pharmaceutical International Corporation Information
• Table 157. Valeant Pharmaceutical International Description and Major Businesses
• Table 158. Valeant Pharmaceutical International Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 159. Valeant Pharmaceutical International Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 160. Valeant Pharmaceutical International Recent Developments
• Table 161. Pfizer Inc Corporation Information
• Table 162. Pfizer Inc Description and Major Businesses
• Table 163. Pfizer Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 164. Pfizer Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 165. Pfizer Inc Recent Developments
• Table 166. Teva Pharmaceuticals Industries Corporation Information
• Table 167. Teva Pharmaceuticals Industries Description and Major Businesses
• Table 168. Teva Pharmaceuticals Industries Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 169. Teva Pharmaceuticals Industries Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 170. Teva Pharmaceuticals Industries Recent Developments
• Table 171. Key Raw Materials Lists
• Table 172. Raw Materials Key Suppliers Lists
• Table 173. Dementia Drugs Distributors List
• Table 174. Dementia Drugs Customers List
• Table 175. Dementia Drugs Market Trends
• Table 176. Dementia Drugs Market Drivers
• Table 177. Dementia Drugs Market Challenges
• Table 178. Dementia Drugs Market Restraints
• Table 179. Research Programs/Design for This Report
• Table 180. Key Data Information from Secondary Sources
• Table 181. Key Data Information from Primary Sources

List of Figures

• Figure 1. Dementia Drugs Product Picture
• Figure 3. Global Dementia Drugs Market Share by Type in 2021 & 2028
• Figure 3. MAO Inhibitors Product Picture
• Figure 4. Cholinesterase Inhibitors Product Picture
• Figure 5. Glutamate Inhibitors Product Picture
• Figure 6. Global Dementia Drugs Market Share by Application in 2021 & 2028
• Figure 7. Hospital Pharmacies
• Figure 8. Retail Pharmacies
• Figure 9. Others
• Figure 10. Dementia Drugs Report Years Considered
• Figure 11. Global Dementia Drugs Sales 2017-2028 (K Units)
• Figure 12. Global Dementia Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 13. Global Dementia Drugs Revenue 2017-2028 (US$ Million)
• Figure 14. Global Dementia Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 15. Global Dementia Drugs Sales Market Share by Region (2017-2022)
• Figure 16. Global Dementia Drugs Sales Market Share by Region (2023-2028)
• Figure 17. North America Dementia Drugs Sales YoY (2017-2028) & (K Units)
• Figure 18. North America Dementia Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 19. Europe Dementia Drugs Sales YoY (2017-2028) & (K Units)
• Figure 20. Europe Dementia Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 21. Asia-Pacific Dementia Drugs Sales YoY (2017-2028) & (K Units)
• Figure 22. Asia-Pacific Dementia Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 23. Latin America Dementia Drugs Sales YoY (2017-2028) & (K Units)
• Figure 24. Latin America Dementia Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 25. Middle East & Africa Dementia Drugs Sales YoY (2017-2028) & (K Units)
• Figure 26. Middle East & Africa Dementia Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 27. The Dementia Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 28. The Top 5 and 10 Largest Manufacturers of Dementia Drugs in the World: Market Share by Dementia Drugs Revenue in 2021
• Figure 29. Global Dementia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 30. Global Dementia Drugs Sales Market Share by Type (2017-2028)
• Figure 31. Global Dementia Drugs Revenue Market Share by Type (2017-2028)
• Figure 32. Global Dementia Drugs Sales Market Share by Application (2017-2028)
• Figure 33. Global Dementia Drugs Revenue Market Share by Application (2017-2028)
• Figure 34. North America Dementia Drugs Sales Market Share by Type (2017-2028)
• Figure 35. North America Dementia Drugs Revenue Market Share by Type (2017-2028)
• Figure 36. North America Dementia Drugs Sales Market Share by Application (2017-2028)
• Figure 37. North America Dementia Drugs Revenue Market Share by Application (2017-2028)
• Figure 38. North America Dementia Drugs Sales Share by Country (2017-2028)
• Figure 39. North America Dementia Drugs Revenue Share by Country (2017-2028)
• Figure 40. U.S. Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 41. Canada Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 42. Europe Dementia Drugs Sales Market Share by Type (2017-2028)
• Figure 43. Europe Dementia Drugs Revenue Market Share by Type (2017-2028)
• Figure 44. Europe Dementia Drugs Sales Market Share by Application (2017-2028)
• Figure 45. Europe Dementia Drugs Revenue Market Share by Application (2017-2028)
• Figure 46. Europe Dementia Drugs Sales Share by Country (2017-2028)
• Figure 47. Europe Dementia Drugs Revenue Share by Country (2017-2028)
• Figure 48. Germany Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 49. France Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 50. U.K. Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 51. Italy Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 52. Russia Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 53. Asia Pacific Dementia Drugs Sales Market Share by Type (2017-2028)
• Figure 54. Asia Pacific Dementia Drugs Revenue Market Share by Type (2017-2028)
• Figure 55. Asia Pacific Dementia Drugs Sales Market Share by Application (2017-2028)
• Figure 56. Asia Pacific Dementia Drugs Revenue Market Share by Application (2017-2028)
• Figure 57. Asia Pacific Dementia Drugs Sales Share by Region (2017-2028)
• Figure 58. Asia Pacific Dementia Drugs Revenue Share by Region (2017-2028)
• Figure 59. China Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 60. Japan Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 61. South Korea Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 62. India Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 63. Australia Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 64. Taiwan Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 65. Indonesia Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 66. Thailand Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 67. Malaysia Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 68. Philippines Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 69. Latin America Dementia Drugs Sales Market Share by Type (2017-2028)
• Figure 70. Latin America Dementia Drugs Revenue Market Share by Type (2017-2028)
• Figure 71. Latin America Dementia Drugs Sales Market Share by Application (2017-2028)
• Figure 72. Latin America Dementia Drugs Revenue Market Share by Application (2017-2028)
• Figure 73. Latin America Dementia Drugs Sales Share by Country (2017-2028)
• Figure 74. Latin America Dementia Drugs Revenue Share by Country (2017-2028)
• Figure 75. Mexico Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 76. Brazil Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 77. Argentina Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 78. Middle East and Africa Dementia Drugs Sales Market Share by Type (2017-2028)
• Figure 79. Middle East and Africa Dementia Drugs Revenue Market Share by Type (2017-2028)
• Figure 80. Middle East and Africa Dementia Drugs Sales Market Share by Application (2017-2028)
• Figure 81. Middle East and Africa Dementia Drugs Revenue Market Share by Application (2017-2028)
• Figure 82. Middle East and Africa Dementia Drugs Sales Share by Country (2017-2028)
• Figure 83. Middle East and Africa Dementia Drugs Revenue Share by Country (2017-2028)
• Figure 84. Turkey Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 85. Saudi Arabia Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 86. U.A.E Dementia Drugs Revenue (2017-2028) & (US$ Million)
• Figure 87. Dementia Drugs Value Chain
• Figure 88. Dementia Drugs Production Process
• Figure 89. Channels of Distribution
• Figure 90. Distributors Profiles
• Figure 91. Bottom-up and Top-down Approaches for This Report
• Figure 92. Data Triangulation
• Figure 93. Key Executives Interviewed